Replies to post #6060 on PharmaCyte Biotech Inc (PMCB)

[DITRstocks]

It’s easy to see why the stock is quickly garnering the attention on several verticals through multiple styles of investors as it could produce incredible gains from current levels of 5.2 cents and a $23 million market cap. Those discerning investors see the massive headroom for share appreciation in both the near and long term for Nuvilex.

NVLX